‘Lung Therapeutics, Inc., a clinical stage biopharmaceutical company developing novel therapeutics for orphan, pulmonary indications, announced today the hiring of Charles T. Garner as Chief Financial Officer and the appointment of R.A. Session, II, to the company’s Board of Directors.’
Lung Therapeutics, Inc. Announces New Chief Financial Officer and Board Member
Source: Business Wire
Read the full article HERE
